Skip to content

Cohort Study on Reducing the Incidence of Renal Injury in Children with Henoch-Schönlein Purpura through TCM Syndrome Differentiation Treatment

Cohort Study on Reducing the Incidence of Renal Injury in Children with Henoch-Schönlein Purpura through TCM Syndrome Differentiation Treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025002524
Enrollment
Unknown
Registered
2025-12-24
Start date
2022-09-15
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Henoch-Schönlein Purpura (HSP)

Interventions

Exposure group:None

Sponsors

Henan University of Traditional Chinese Medicine First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1) Initial-onset children meeting the above diagnostic criteria for HSP, with disease duration not exceeding 2 weeks 2) TCM syndrome patterns conforming to blood-heat reckless movement syndrome or wind-heat injuring collaterals syndrome 3) Age between 2-18 years 4) No prior heparin use before treatment 5) Parental consent for clinical observation.

Exclusion criteria

Exclusion criteria: Exclusion criteria (any one of the following): 1) Not meeting inclusion criteria 2) Allergy to known preparations 3) Coagulation disorders or other hemorrhagic diseases 4) Severe primary diseases involving cardiovascular, hepatic, renal or hematopoietic systems, or psychiatric disorders 5) Uncooperative family members or children.

Design outcomes

Primary

MeasureTime frame
Urinalysis;24-hour urinary protein quantification;

Countries

China

Contacts

Public ContactRen Xianqing

Henan University of Traditional Chinese Medicine First Affiliated Hospital

renxq723@163.com15638251798

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026